ISLET SCIENCES INC

Islet Sciences Inc Stock

Stocks

ISLT

US46467R1095

Biotechnology & Medical Research

OTC Markets Traded

Delayed OTC Markets 16:53:58 26/07/2017 +03			5-day change	1st Jan Change
0.0127 ^USD	+5.75%		+5.75%	-76.93%

Press Releases: Islet Sciences Inc

04/05/15	Islet Sciences, Inc. Publishes Data Supporting Remogliflozin Etabonate as a Potential Treatment for NAFLD and NASH	GL
23/04/15	Islet Sciences, Inc. Presented at 50th International Liver Conference	GL
24/03/15	Islet Sciences, Inc. COO to Present at Metabolic Leaders Forum	GL
09/03/15	Islet Sciences, Inc. COO to Present at EASL: Remogliflozin Etabonate as Novel Treatment for Non-alcoholic Steatohepatitis (NASH)	GL
05/03/15	Islet Sciences, Inc. Confirms Issuance of U.S. Patent for Using SGLT2 Inhibitors to Treat NASH/NAFLD	GL

More press releases

Quotes and Performance

1 day

+5.75%

Other Biotechnology & Medical Research

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
	ISLET SCIENCES INC	+5.75%	+5.75%	-	-	0
	LONZA GROUP AG	-0.11%	0.00%	-1.97%	+26.80%	45.81B
	REVOLUTION MEDICINES, INC.	-2.04%	-3.49%	+348.38%	+548.00%	43.91B
	IQVIA HOLDINGS INC.	-0.01%	+5.14%	+44.64%	+29.06%	44.39B
	BEONE MEDICINES AG	-0.48%	-1.63%	+5.52%	+65.27%	39.4B
	CELLTRION, INC.	-0.73%	-3.06%	+9.63%	+38.92%	31.26B
	ASCENDIS PHARMA A/S	+0.07%	-7.76%	-	-	15.75B
	MEDPACE HOLDINGS, INC.	-0.49%	+5.21%	+25.69%	+125.87%	17.32B
	EUROFINS SCIENTIFIC SE	+0.82%	+4.43%	+18.26%	+34.64%	14.73B
	CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-0.12%	-2.19%	+79.59%	+29.29%	13.03B
	Average	+0.27%	-1.20%	+66.22%	+112.23%	29.51B
	Weighted average by Cap.	-0.49%	-1.23%	+77.88%	+133.85%

See all sector performances

Company Profile

Employees

-

Sector

Biotechnology & Medical Research

More about the company

Stock Market
Stocks
ISLT Stock

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!

SEIZE THE OFFER!